Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion. Oeckl P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al. J Neurol Neurosurg Psychiatry 2022 Apr 27. pii: jnnp-2021-328547.

Read + Share

Amedeo Smart

Independent Medical Education

Oeckl P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al. Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J Neurol Neurosurg Psychiatry 2022 Apr 27. pii: jnnp-2021-328547.
PMID: 35477892